• 2017 Arnall Patz Lecture

    Neil M. Bressler, MD, previews his 2017 Arnall Patz Lecture: DRCR Network: Accomplishments and Vision for the Future.

    “Americans, across all races and ethnicities, rate losing eyesight as having the greatest impact on their daily lives. When this fact is coupled with the diabetes epidemic in the United States and throughout the world, and recognizing that the most common complication of diabetes is diabetic retinopathy, the DRCR Network was established in 2003 with the National Institutes of Health to facilitate multicenter clinical research on diabetic retinopathy and associated conditions. By 2017, the Network involved more than 300 clinical sites, over 1,000 retina specialists in North America, and almost 10,000 study participants across 25 protocols, resulting in over 70 publications that have contributed to major improvements in the management of diabetic macular edema and proliferative diabetic retinopathy. Its major novel and clinically relevant accomplishments, to be highlighted during the Arnall Patz Lecture, have been recognized by the U.S. Senate and U.S. House of Representatives. The NIH has agreed that the Network could change its scope for the future to include such conditions as age-related macular degeneration and related diseases as part of the continued efforts by the Network to contribute to ophthalmology’s pursuits to combat vision impairment and blindness.”—Dr. Bressler

    When: Monday Nov. 13, 8:35-8:55 a.m., during Sym27, Current Management of Neovascular AMD, at AAO 2017. 
    Where: La Nouvelle Orleans AB.

    Current Management of Neovascular AMD (8:30-10:00 a.m.) is cosponsored by the Macula Society.

    This preview was excerpted from EyeNet AAO 2017 News, a tabloid distributed at the Morial Convention Center.